Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 16 | $8,730,520 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 02 Apr 2024 16:06 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 01 Apr 2024 | Sale | 4,000 | 58.66 | 234,640 | D |
| 05 Mar 2024 16:04 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 01 Mar 2024 | Sale | 2,000 | 63.95 | 127,900 | D |
| 05 Mar 2024 16:04 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 01 Mar 2024 | Sale | 4,000 | 62.86 | 251,440 | D |
| 13 Feb 2024 16:59 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 12 Feb 2024 | Sale | 1,431 | 67.7669 | 96,974 | D |
| 31 Jan 2024 16:34 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 29 Jan 2024 | Sale | 906 | 64.1382 | 58,109 | D |
| 23 Jan 2024 18:13 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 22 Jan 2024 | Sale | 3,551 | 64.996 | 230,801 | D |
| 17 Jan 2024 16:36 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 16 Jan 2024 | Sale | 2,235 | 66.8086 | 149,317 | D |
| 01 Dec 2023 16:11 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 30 Nov 2023 | Sale | 300 | 54.7866 | 16,436 | D |
| 01 Dec 2023 16:11 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 30 Nov 2023 | Sale | 13,858 | 54.73 | 758,448 | D |
| 06 Jul 2023 16:16 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 03 Jul 2023 | Sale | 300 | 91.0983 | 27,329 | D |
| 06 Jul 2023 16:16 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 03 Jul 2023 | Sale | 3,287 | 90.4165 | 297,199 | D |
| 06 Jul 2023 16:16 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 03 Jul 2023 | Sale | 3,192 | 89.4109 | 285,400 | D |
| 06 Jun 2023 16:59 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 05 Jun 2023 | Sale | 30,506 | 89.8259 | 2,740,229 | D |
| 06 Jun 2023 16:59 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 05 Jun 2023 | Sale | 7,064 | 88.3649 | 624,210 | D |
| 06 Jun 2023 16:59 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 05 Jun 2023 | Sale | 30,609 | 87.7886 | 2,687,121 | D |
| 06 Jun 2023 16:59 | APLS | Apellis Pharmaceuticals Inc | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 05 Jun 2023 | Sale | 1,600 | 90.6044 | 144,967 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)